Clinical Trial

A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS

Name: A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS — clinical trial record (NCT07728097)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: EpiGOAL

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This is a Phase 3b/Phase 4 study. The purpose of this study is to learn more about the efficacy of using CBD-OS as an add-on therapy for the treatment of LGS in adults.

Trial Details

NCT Number	NCT07728097
Lead Sponsor	Jazz Pharmaceuticals Collaborators: Jazz Pharmaceuticals Research UK Limited
Conditions	Lennox-Gastaut Syndrome
Enrollment	40 participants
Start Date	2026-11-18
Primary Completion	2028-12-28 (estimated)
Study Completion	2028-12-28 (estimated)
Updated on ClinicalTrials.gov	2026-07-27